Fundraising FoxNan Fung Life Sciences — Full Portfolio
6 tracked investments · listed companies and verified rows first
Bolt Biotherapeutics is a clinical-stage biotech company developing novel immunotherapies that leverage innate immune system mechanisms to treat cancer.
BiotechHealthtechMedical DevicesSan Francisco, US
Dr. Edgar G. Engleman(Founder)
Co-investorsPfizer Venture InvestmentsPivotal Life SciencesRA CapitalSamsara BioCapitalSofinnova VenturesVivo Capital+3 more
BiotechEvanston, US
Joseph R. Moskal(Chief Scientific Officer)Torsten M. Madsen(Chief Marketing Officer)Ashish Khanna(Secretary & Chief Business Officer)Norbert G. Riedel(Chief Executive Officer)
BoardLiam Ratcliffe(Director)Terry P. Gould(Director)
Co-investorsBain Capital Life SciencesFrazier Life SciencesLatterell Venture PartnersLongitude CapitalOUP (Osage University Partners)Agent Capital+3 more
Eargo was a hearing aid company that provided high-quality hearing aids and related care services.
HealthtechMedical DevicesMountain View, US
Raphael Michel(Founder)Christian Gormsen(Executive Officer, Director)William Brownie(Executive Officer)Peter Tuxen Bisgaard(Director)Daniel Shen(Founder)Florent Michel(Founder)
Co-investorsBirchmere VenturesDolby Family VenturesLongitude CapitalMaveronNew Enterprise Associates (NEA)Peterson Ventures+4 more
San Diego protein-sequencing company behind the ProteoCode platform; ceased operations in late 2025.
Co-investorsARCH Venture PartnersDecheng CapitalAlexandriaDeerfield Management CompanyGV (Google Ventures)Northpond Ventures
Fountain is a biotech company developing first-in-class therapies for diseases and conditions caused by aging, using in vitro and in vivo screening platforms to identify drug candidates.
BiotechHealthtechLongevitySan Francisco, US
Thomas Rando(Co-founder)Joseph Rodgers(Co-founder)inTom Cheung(Co-founder)inTsang(Chief Business Officer)
Co-investorsAlexandriaKhosla VenturesR42 Group
San Diego DNA sequencing company behind the Sequencing by Binding short-read platform; acquired by Pacific Biosciences in 2021.
BiotechSan Diego, US
David S. Mullarkey(Executive Officer, Director)Arnold Oliphant(Executive Officer)inKen Song, M.D., Ph.D.(Executive Officer, Director)Kelly Perez(Executive Officer)John Murphy, Ph.D.(Executive Officer)Millard Y Chan(Chief Operating Officer, Secretary and Director)
Co-investorsARCH Venture PartnersATEL VenturesDCVC (Data Collective)Decheng CapitalLam CapitalPivotal Life Sciences+3 more
BiotechWaltham, US
Chrystiyna Bedrij(Director)Peter Bisgaard(Director)Vincent Cheung(Director)Laura Benjamin(Director)Benjamin Chen(Director)
Co-investorsK2 HealthVenturesPivotal bioVenture Partners ChinaVolcanics Venture
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.